IBDEI0LO ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1517,0)
 ;;=IMRT PLAN^3^133
 ;;^UTILITY(U,$J,358.4,1518,0)
 ;;=TREATMENT DELIVERY^8^133
 ;;^UTILITY(U,$J,358.4,1519,0)
 ;;=BRACHYTHERAPY ISODOSE PLAN^1^133
 ;;^UTILITY(U,$J,358.4,1520,0)
 ;;=STEREOTACTIC TREATMENT^6^133
 ;;^UTILITY(U,$J,358.4,1521,0)
 ;;=ASPIRATION/INJECTION^1^134
 ;;^UTILITY(U,$J,358.4,1522,0)
 ;;=INJECTION MEDICATIONS^2^134
 ;;^UTILITY(U,$J,358.4,1523,0)
 ;;=ULTRASOUND^3^134
 ;;^UTILITY(U,$J,358.4,1524,0)
 ;;=NEW PATIENT^2^135
 ;;^UTILITY(U,$J,358.4,1525,0)
 ;;=ESTABLISHED PATIENT^1^135
 ;;^UTILITY(U,$J,358.4,1526,0)
 ;;=CONSULTATIONS^3^135
 ;;^UTILITY(U,$J,358.4,1527,0)
 ;;=INFLAMMATORY CONDITIONS^4^136
 ;;^UTILITY(U,$J,358.4,1528,0)
 ;;=OSTEOARTHRITIS^7^136
 ;;^UTILITY(U,$J,358.4,1529,0)
 ;;=SPINE DISORDERS^12^136
 ;;^UTILITY(U,$J,358.4,1530,0)
 ;;=INTERNAL DERANGEMENT OF KNEE^5^136
 ;;^UTILITY(U,$J,358.4,1531,0)
 ;;=JOINT DISORDERS^6^136
 ;;^UTILITY(U,$J,358.4,1532,0)
 ;;=TENDINITIS & BURSITIS^13^136
 ;;^UTILITY(U,$J,358.4,1533,0)
 ;;=SIGNS & SYMPTOMS^11^136
 ;;^UTILITY(U,$J,358.4,1534,0)
 ;;=VASCULITIS CONDITIONS^14^136
 ;;^UTILITY(U,$J,358.4,1535,0)
 ;;=CRYSTAL ARTHROPATHIES^3^136
 ;;^UTILITY(U,$J,358.4,1536,0)
 ;;=OSTEOPOROSIS^9^136
 ;;^UTILITY(U,$J,358.4,1537,0)
 ;;=OSTEOMYELITIS^8^136
 ;;^UTILITY(U,$J,358.4,1538,0)
 ;;=PYOGENIC ARTHRITIS^10^136
 ;;^UTILITY(U,$J,358.4,1539,0)
 ;;=COMMON DIAGNOSES^1^136
 ;;^UTILITY(U,$J,358.4,1540,0)
 ;;=AUTOIMMUNE DISORDERS^2^136
 ;;^UTILITY(U,$J,358.4,1541,0)
 ;;=VACCINATIONS^12^137
 ;;^UTILITY(U,$J,358.4,1542,0)
 ;;=INJECTION^6^137
 ;;^UTILITY(U,$J,358.4,1543,0)
 ;;=EDUCATION/TRAINING^2^137
 ;;^UTILITY(U,$J,358.4,1544,0)
 ;;=COUNSELING^1^137
 ;;^UTILITY(U,$J,358.4,1545,0)
 ;;=EVALUATIONS^3^137
 ;;^UTILITY(U,$J,358.4,1546,0)
 ;;=SPINAL INJECTION CODES^8^137
 ;;^UTILITY(U,$J,358.4,1547,0)
 ;;=SUPPLIES^9^137
 ;;^UTILITY(U,$J,358.4,1548,0)
 ;;=TREATMENT PROCEDURES^10^137
 ;;^UTILITY(U,$J,358.4,1549,0)
 ;;=TRIGGER POINT INJECTIONS^11^137
 ;;^UTILITY(U,$J,358.4,1550,0)
 ;;=HOME VISIT-ESTABLISHED PT^4^137
 ;;^UTILITY(U,$J,358.4,1551,0)
 ;;=HOME VISIT-NEW PT^5^137
 ;;^UTILITY(U,$J,358.4,1552,0)
 ;;=ON-LINE MEDICAL EVAL^7^137
 ;;^UTILITY(U,$J,358.4,1553,0)
 ;;=OTHER/MISC DIAGNOSES^6^138
 ;;^UTILITY(U,$J,358.4,1554,0)
 ;;="E" CODES-SECONDARY ONLY^2^138
 ;;^UTILITY(U,$J,358.4,1555,0)
 ;;=ULCER^10^138
 ;;^UTILITY(U,$J,358.4,1556,0)
 ;;=MUSCULOSKELETAL^4^138
 ;;^UTILITY(U,$J,358.4,1557,0)
 ;;=NEPHRO/GU/GI^5^138
 ;;^UTILITY(U,$J,358.4,1558,0)
 ;;=CARDIOVASCULAR^1^138
 ;;^UTILITY(U,$J,358.4,1559,0)
 ;;=PARAPLEGIA^7^138
 ;;^UTILITY(U,$J,358.4,1560,0)
 ;;=QUADRAPLEGIA^8^138
 ;;^UTILITY(U,$J,358.4,1561,0)
 ;;=MENTAL HEALTH^3^138
 ;;^UTILITY(U,$J,358.4,1562,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^9^138
 ;;^UTILITY(U,$J,358.4,1563,0)
 ;;=NEW PT-OFFICE^3^139
 ;;^UTILITY(U,$J,358.4,1564,0)
 ;;=ESTABLISHED PT-OFFICE^1^139
 ;;^UTILITY(U,$J,358.4,1565,0)
 ;;=CONSULTATIONS^5^139
 ;;^UTILITY(U,$J,358.4,1566,0)
 ;;=COGNITIVE DISORDERS^1^140
 ;;^UTILITY(U,$J,358.4,1567,0)
 ;;=DEVELOPMENTAL DISORDERS^2^140
 ;;^UTILITY(U,$J,358.4,1568,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DIS^5^140
 ;;^UTILITY(U,$J,358.4,1569,0)
 ;;=VOCAL FOLD DISORDER^10^140
 ;;^UTILITY(U,$J,358.4,1570,0)
 ;;=OTHER SPEECH DISORDERS^7^140
 ;;^UTILITY(U,$J,358.4,1571,0)
 ;;=HISTORY OF MALIGNANCY^3^140
 ;;^UTILITY(U,$J,358.4,1572,0)
 ;;=PSYCHOGENIC^8^140
 ;;^UTILITY(U,$J,358.4,1573,0)
 ;;=SWALLOWING DISORDER^9^140
 ;;^UTILITY(U,$J,358.4,1574,0)
 ;;=HISTORY/STATUS CODES^4^140
 ;;^UTILITY(U,$J,358.4,1575,0)
 ;;=NON-PSYCHOTIC MENTAL DISORDER^6^140
 ;;^UTILITY(U,$J,358.4,1576,0)
 ;;=ESTABLISHED PATIENT^2^141
 ;;^UTILITY(U,$J,358.4,1577,0)
 ;;=GROUP TREATMENT^3^142
 ;;^UTILITY(U,$J,358.4,1578,0)
 ;;=VOICE PROSTHESES^9^142
 ;;^UTILITY(U,$J,358.4,1579,0)
 ;;=AAC DEVICES^1^142
 ;;^UTILITY(U,$J,358.4,1580,0)
 ;;=OTHER PROCEDURES^6^142
 ;;^UTILITY(U,$J,358.4,1581,0)
 ;;=LARYNGOSCOPY PROCEDURES^4^142
 ;;^UTILITY(U,$J,358.4,1582,0)
 ;;=NASOPHARYNGOSCOPY^5^142
 ;;^UTILITY(U,$J,358.4,1583,0)
 ;;=DYSPHAGIA EVALUATION^2^142
 ;;^UTILITY(U,$J,358.4,1584,0)
 ;;=SPECIAL OTORHINOLARYNGOLOGIC SERVICES^8^142
 ;;^UTILITY(U,$J,358.4,1585,0)
 ;;=SCREENING^7^142
 ;;^UTILITY(U,$J,358.4,1586,0)
 ;;=OTHER^4^143
 ;;^UTILITY(U,$J,358.4,1587,0)
 ;;=CASE MANAGEMENT SERVICES^1^143
 ;;^UTILITY(U,$J,358.4,1588,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^3^143
 ;;^UTILITY(U,$J,358.4,1589,0)
 ;;=EDUCATION/TRAINING^2^143
 ;;^UTILITY(U,$J,358.4,1590,0)
 ;;=PSYCHIATRIC THERAPY^5^143
 ;;^UTILITY(U,$J,358.4,1591,0)
 ;;=ADJUSTMENT DISORDERS^2^144
 ;;^UTILITY(U,$J,358.4,1592,0)
 ;;=ANXIETY DISORDERS^4^144
 ;;^UTILITY(U,$J,358.4,1593,0)
 ;;=AMNESTICS^3^144
 ;;^UTILITY(U,$J,358.4,1594,0)
 ;;=ORGANIC DISORDERS^13^144
 ;;^UTILITY(U,$J,358.4,1595,0)
 ;;=DEMENTIA^8^144
 ;;^UTILITY(U,$J,358.4,1596,0)
 ;;=DELIRIUM^7^144
 ;;^UTILITY(U,$J,358.4,1597,0)
 ;;=BIPOLAR DISORDERS^5^144
 ;;^UTILITY(U,$J,358.4,1598,0)
 ;;=PSYCHOSIS/OTHER^17^144
 ;;^UTILITY(U,$J,358.4,1599,0)
 ;;=PERSONALITY DISORDERS^15^144
 ;;^UTILITY(U,$J,358.4,1600,0)
 ;;=SEXUAL DISORDERS^19^144
 ;;^UTILITY(U,$J,358.4,1601,0)
 ;;=SLEEP DISORDERS^20^144
 ;;^UTILITY(U,$J,358.4,1602,0)
 ;;=OTHER DISORDERS^14^144
 ;;^UTILITY(U,$J,358.4,1603,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^144
 ;;^UTILITY(U,$J,358.4,1604,0)
 ;;=V CODES^23^144
 ;;^UTILITY(U,$J,358.4,1605,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^144
 ;;^UTILITY(U,$J,358.4,1606,0)
 ;;=DEPRESSION^9^144
 ;;^UTILITY(U,$J,358.4,1607,0)
 ;;=MOOD DISORDERS (OTHER)^11^144
 ;;^UTILITY(U,$J,358.4,1608,0)
 ;;=SCHIZOPHRENIA^18^144
 ;;^UTILITY(U,$J,358.4,1609,0)
 ;;=SOMATIFORM DISORDERS^21^144
 ;;^UTILITY(U,$J,358.4,1610,0)
 ;;=EATING DISORDERS^10^144
 ;;^UTILITY(U,$J,358.4,1611,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^144
 ;;^UTILITY(U,$J,358.4,1612,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^144
 ;;^UTILITY(U,$J,358.4,1613,0)
 ;;=BRAIN DISORDERS^6^144
 ;;^UTILITY(U,$J,358.4,1614,0)
 ;;=PSYCHIATRIC THERAPY^8^145
 ;;^UTILITY(U,$J,358.4,1615,0)
 ;;=OTHER^7^145
 ;;^UTILITY(U,$J,358.4,1616,0)
 ;;=CASE MANAGEMENT SERVICES^1^145
 ;;^UTILITY(U,$J,358.4,1617,0)
 ;;=HOME HEALTH VISIT^5^145
 ;;^UTILITY(U,$J,358.4,1618,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^145
 ;;^UTILITY(U,$J,358.4,1619,0)
 ;;=SMOKING/TOBACCO USE CESSATION^9^145
 ;;^UTILITY(U,$J,358.4,1620,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^145
 ;;^UTILITY(U,$J,358.4,1621,0)
 ;;=EDUCATION/TRAINING^3^145
 ;;^UTILITY(U,$J,358.4,1622,0)
 ;;=ADJUSTMENT DISORDERS^2^146
 ;;^UTILITY(U,$J,358.4,1623,0)
 ;;=ANXIETY DISORDERS^4^146
 ;;^UTILITY(U,$J,358.4,1624,0)
 ;;=AMNESTICS^3^146
 ;;^UTILITY(U,$J,358.4,1625,0)
 ;;=ORGANIC DISORDERS^13^146
 ;;^UTILITY(U,$J,358.4,1626,0)
 ;;=DEMENTIA^8^146
 ;;^UTILITY(U,$J,358.4,1627,0)
 ;;=DELIRIUM^7^146
 ;;^UTILITY(U,$J,358.4,1628,0)
 ;;=BIPOLAR DISORDERS^5^146
 ;;^UTILITY(U,$J,358.4,1629,0)
 ;;=PSYCHOSIS/OTHER^17^146
 ;;^UTILITY(U,$J,358.4,1630,0)
 ;;=PERSONALITY DISORDERS^15^146
 ;;^UTILITY(U,$J,358.4,1631,0)
 ;;=SEXUAL DISORDERS^19^146
 ;;^UTILITY(U,$J,358.4,1632,0)
 ;;=SLEEP DISORDERS^20^146
 ;;^UTILITY(U,$J,358.4,1633,0)
 ;;=OTHER DISORDERS^14^146
 ;;^UTILITY(U,$J,358.4,1634,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^146
 ;;^UTILITY(U,$J,358.4,1635,0)
 ;;=V CODES^23^146
 ;;^UTILITY(U,$J,358.4,1636,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^146
 ;;^UTILITY(U,$J,358.4,1637,0)
 ;;=DEPRESSION^9^146
 ;;^UTILITY(U,$J,358.4,1638,0)
 ;;=MOOD DISORDERS (OTHER)^11^146
 ;;^UTILITY(U,$J,358.4,1639,0)
 ;;=SCHIZOPHRENIA^18^146
 ;;^UTILITY(U,$J,358.4,1640,0)
 ;;=SOMATIFORM DISORDERS^21^146
 ;;^UTILITY(U,$J,358.4,1641,0)
 ;;=EATING DISORDERS^10^146
 ;;^UTILITY(U,$J,358.4,1642,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^146
 ;;^UTILITY(U,$J,358.4,1643,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^146
 ;;^UTILITY(U,$J,358.4,1644,0)
 ;;=BRAIN DISORDERS^6^146
 ;;^UTILITY(U,$J,358.4,1645,0)
 ;;=NEW PATIENT^2^147
 ;;^UTILITY(U,$J,358.4,1646,0)
 ;;=ESTABLISHED PATIENT^1^147
 ;;^UTILITY(U,$J,358.4,1647,0)
 ;;=CONSULTATIONS^3^147
 ;;^UTILITY(U,$J,358.4,1648,0)
 ;;=TELEHEALTH FACILITY FEE^1^148
 ;;^UTILITY(U,$J,358.4,1649,0)
 ;;=ABRASION w/o INFECTION^1^149
 ;;^UTILITY(U,$J,358.4,1650,0)
 ;;=ABRASION w/ INFECTION^2^149
 ;;^UTILITY(U,$J,358.4,1651,0)
 ;;=ABSCESS/CELLULITIS^3^149
 ;;^UTILITY(U,$J,358.4,1652,0)
 ;;=ACNE^4^149
 ;;^UTILITY(U,$J,358.4,1653,0)
 ;;=ALOPEICA^5^149
 ;;^UTILITY(U,$J,358.4,1654,0)
 ;;=BURNS^6^149
 ;;^UTILITY(U,$J,358.4,1655,0)
 ;;=CANDIDIASIS^7^149
 ;;^UTILITY(U,$J,358.4,1656,0)
 ;;=CELLULITIS^8^149
 ;;^UTILITY(U,$J,358.4,1657,0)
 ;;=DERMATITIS^9^149
 ;;^UTILITY(U,$J,358.4,1658,0)
 ;;=DERMATOPHYTOSIS^10^149
 ;;^UTILITY(U,$J,358.4,1659,0)
 ;;=ECZEMA^11^149
 ;;^UTILITY(U,$J,358.4,1660,0)
 ;;=EDEMA^12^149
 ;;^UTILITY(U,$J,358.4,1661,0)
 ;;=ERYTHEMA^13^149
 ;;^UTILITY(U,$J,358.4,1662,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^149
 ;;^UTILITY(U,$J,358.4,1663,0)
 ;;=FOLLICULITIS^15^149
 ;;^UTILITY(U,$J,358.4,1664,0)
 ;;=FURUNCLE^16^149
 ;;^UTILITY(U,$J,358.4,1665,0)
 ;;=GRANULOMA^17^149
 ;;^UTILITY(U,$J,358.4,1666,0)
 ;;=HERPES^35^149
 ;;^UTILITY(U,$J,358.4,1667,0)
 ;;=HISTORY^36^149
 ;;^UTILITY(U,$J,358.4,1668,0)
 ;;=ICHTHYOSIS^38^149
 ;;^UTILITY(U,$J,358.4,1669,0)
 ;;=INSECT BITE w/o INFECTION^39^149
 ;;^UTILITY(U,$J,358.4,1670,0)
 ;;=INSECT BITE w/INFECTION^40^149
 ;;^UTILITY(U,$J,358.4,1671,0)
 ;;=KERATOSIS^42^149
 ;;^UTILITY(U,$J,358.4,1672,0)
 ;;=LACERATION^44^149
 ;;^UTILITY(U,$J,358.4,1673,0)
 ;;=LESION^46^149
 ;;^UTILITY(U,$J,358.4,1674,0)
 ;;=LICHENIFICATION^47^149
 ;;^UTILITY(U,$J,358.4,1675,0)
 ;;=LUPUS^48^149
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;=MELANOMA^50^149
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;=NAIL DISEASE^53^149
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;=NEOPLASM-BENIGN^54^149
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;=NEOPLASM-IN SITU^56^149
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;=NEOPLASM-OTHER^57^149
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;=NEURODERMATITIS^58^149
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;=PEDICULOSIS^61^149
